Construction
- 1460.435
- +3.931+0.27%
Analysts Have Conflicting Sentiments on These Healthcare Companies: Raffles Medical Group (OtherRAFLF), Cencora (COR) and Acadia Healthcare (ACHC)
Raffles Medical Group Receives Hold Rating Amid Financial Challenges and Competitive Pressures
DBS Adjusts Raffles Medical Group's Price Target to SG$0.97 From SG$1, Keeps at Hold
Maintaining Hold on Raffles Medical Group Amidst Mixed Performance and Market Challenges
Raffles Medical Group (RAFLF) Receives a Hold From DBS
Maybank Adjusts Dyna-Mac Holdings' Price Target to SG$0.62 From SG$0.52, Keeps at Buy
SAC Capital Starts ISOTeam at Buy With SG$0.073 Price Target
Maybank Securities Adjusts Dyna-Mac Holdings' Price Target to SG$0.52 From SG$0.46, Keeps at Buy
SAC Capital Starts Soilbuild Construction at Buy With SG$0.04 Price Target
OCBC Investment Research Adjusts Dyna-Mac's Price Target to SG$0.445 From SG$0.42, Keeps at Buy
CGS-CIMB Research Adjusts Raffles Medical Group's Price Target to SG$1.16 From SG$1.20, Keeps at Buy
Analysts Offer Insights on Healthcare Companies: Raffles Medical Group (OtherRAFLF), Agilent (A) and Karuna Therapeutics (KRTX)
RHB Bank Singapore Adjusts ISOTeam's Price Target to SG$0.048 From SG$0.054, Keeps at Buy
Maybank Securities Adjusts Dyna-Mac's Price Target to SG$0.38 From SG$0.51, Keeps at Buy
Maybank Securities Downgrades Raffles Medical Group to Hold From Buy, Adjusts Price Target to SG$1.30 From SG$1.65
Hold Rating on Raffles Medical Group Amid Declining Profits and Rising Operational Costs
Nomura Adjusts Raffles Medical's Price Target to SG$1.40 From SG$1.60, Keeps at Buy
Raffles Medical Group's Strategic Expansion and Growth Potential: A Buy Recommendation
UOB Kay Hian Keeps Their Buy Rating on Raffles Medical Group (RAFLF)
Maybank Adjusts Civmec's Price Target to SG$1.05 From SG$1, Keeps at Buy